Proprietary AI platform using deep learning models built on billions of dynamic gene expression changes throughout disease progression to map causal disease trajectories and rev...
Proprietary AI platform using deep learning models built on billions of dynamic gene expression changes throughout disease progression to map causal disease trajectories and reversal. Integrates with AlgenCRISPR for end-to-end drug discovery spanning disease modeling, target discovery, molecule identification, and clinical translation.
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Loading community reviews…
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.